Literature DB >> 33188851

Soluble epoxide hydrolase inhibitors improve angiogenic function of endothelial progenitor cells via ERK/p38-mediated miR-126 upregulation in myocardial infarction mice after exercise.

Yajun Gui1, Jingyuan Chen2, Jiahui Hu2, Caixiu Liao3, Minzhi Ouyang4, Limin Deng1, Jingmin Yang2, Danyan Xu5.   

Abstract

It is well established that exercise could protect against myocardial infarction (MI). Previously, we found that epoxyeicosatrienoic acids (EETs) could be induced by exercise and has been found to protect against MI via promoting angiogenic function of endothelial progenitor cells (EPCs). However, the underling mechanism of EETs in promoting EPC functions is unclear. C57BL/6 mice were fed with a novel soluble epoxide hydrolase inhibitor (sEHi), TPPU, to increase EET levels, for 1 week before undergoing MI surgery. Mice were then subjected to exercise training for 4 weeks. Bone marrow-derived EPCs were isolated and cultured in vitro. Exercise upregulated miR-126 expression but downregulated the protein levels of its target gene, Spred1, in EPCs from MI mice. TPPU further enhanced the effects of exercise on EPCs. Spred1 overexpression abolished the protective effects of TPPU on EPC functions. Downregulation of miR-126 by antagomiR-126 impaired the inhibitor effects of TPPU on Spred1 mRNA and protein expression. Additionally, TPPU upregulated miR-126 is partially mediated through ERK/p38 MAPK pathway. This study showed that sEHi promoted miR-126 expression, which might be related to the beneficial effect of sEHi on EPC functions in MI mice under exercise conditions, by increasing ERK and p38 MAPK phosphorylation and inhibiting Spred1.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelial progenitor cells; Exercise; Myocardial infarction; Soluble epoxide hydrolase inhibitor; Sprouty-related proteins with an EVH1 domain; microRNA-126

Mesh:

Substances:

Year:  2020        PMID: 33188851     DOI: 10.1016/j.yexcr.2020.112360

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

Review 1.  Epoxylipids and soluble epoxide hydrolase in heart diseases.

Authors:  John D Imig; Ludek Cervenka; Jan Neckar
Journal:  Biochem Pharmacol       Date:  2021-12-02       Impact factor: 5.858

2.  MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis.

Authors:  Yali Yan; Mengmeng Zhu; Jialing Ma; Xiaoyu He; Xiaoxiao Yang; Hongmei Xu; Meixiu Jiang; Shuang Zhang; Yajun Duan; Jihong Han; Yuanli Chen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  Soluble Epoxide Hydrolase Inhibitor t-AUCB Ameliorates Vascular Endothelial Dysfunction by Influencing the NF-κB/miR-155-5p/eNOS/NO/IκB Cycle in Hypertensive Rats.

Authors:  Xiaorui Wang; Wenwen Han; Yi Zhang; Yi Zong; Na Tan; Yan Zhang; Li Li; Chang Liu; Limei Liu
Journal:  Antioxidants (Basel)       Date:  2022-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.